Table 2. Baseline Characteristics of the International Study Population Stratified According to 30-day Potentially Avoidable Readmission.
No. (%) of patients |
||
---|---|---|
Clinical Characteristics | Without 30-day PAR (n=112,418) |
With 30-day PAR (n =11,794) |
Age, mean (SD) | 60.8 (18.3) | 61.3 (18.0) |
| ||
Male sex | 53,679 (51%) | 5,988 (53%) |
| ||
Country | ||
| ||
United States | 70,550 (89.4%) | 8,371 (10.6%) |
| ||
Canada | 10,221 (92.6%) | 820 (7.4%) |
| ||
Switzerland | 8,971 (94.5%) | 524 (5.5%) |
| ||
Israel | 16,016 (91.0%) | 1,592 (9.0%) |
| ||
Urgent or Emergent index admission | 78,708 (74%) | 9,369 (83%) |
| ||
Discharge from an oncology division | 6,457 (6.1%) | 786 (7.0%) |
| ||
Length of stay of the index admission ≥ 5 days | 45,655 (43%) | 6,058 (54%) |
| ||
Number of hospital admissions in the past year | ||
| ||
≤ 1 | 76,196 (72%) | 4,826 (43%) |
| ||
2-5 | 25,109 (24%) | 4,464 (40%) |
| ||
> 5 | 4,453 (4%) | 2,017 (18%) |
| ||
≥ 1 procedure during the index hospitalization | 78,818 (75%) | 8,781 (78%) |
| ||
Low hemoglobin level at discharge (< 12 g/dL) | 59,381 (56%) | 8,005 (71%) |
| ||
Low sodium level at discharge ( < 135 mmol/L) | 13,520 (13%) | 2,038 (18%) |
PAR: potentially avoidable readmission